1974
DOI: 10.1056/nejm197401312900502
|View full text |Cite
|
Sign up to set email alerts
|

Hyperglucagonemia in Laennec's Cirrhosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
26
0
1

Year Published

1974
1974
1991
1991

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 233 publications
(29 citation statements)
references
References 24 publications
2
26
0
1
Order By: Relevance
“…The peripheral hyperinsulinemia that has been described after portacaval shunt [3,14,15] was not consistently seen. However, increased glucagon levels in the systemic venous blood were regularly observed in confirmation of earlier reports [26,30,31], As might be expected with hyperglucagonemia in combination with a bypassing of insulin around the liver, the hepatic cyclic AMP was consistently elevated in the dogs, but, surprisingly, not in the baboons. The canine increases occurred in spite of the fact that cyclic AMP production as measured by the aminophylline test was not strikingly increased.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…The peripheral hyperinsulinemia that has been described after portacaval shunt [3,14,15] was not consistently seen. However, increased glucagon levels in the systemic venous blood were regularly observed in confirmation of earlier reports [26,30,31], As might be expected with hyperglucagonemia in combination with a bypassing of insulin around the liver, the hepatic cyclic AMP was consistently elevated in the dogs, but, surprisingly, not in the baboons. The canine increases occurred in spite of the fact that cyclic AMP production as measured by the aminophylline test was not strikingly increased.…”
Section: Discussionsupporting
confidence: 87%
“…Alternatively, Eaton [16] has proposed that changes in glucagon metabolism might be important in causing the antilipidemic effect. Portacaval shunting has also been demonstrated to cause increases in serum glucagon concentration [26,30,31]. Glucagon in pharmacologic [27] or physiologic [37] doses has been shown to decrease hepatic cholesterol synthesis possibly via an increase in hepatic cyclic adenosine 3′,5′-monophosphate (cyclic AMP).…”
Section: Discussionmentioning
confidence: 99%
“…Previous reports have indicated that 0.1-1.0 mM NH4+ inhibits glucose-stimulated insulin release both in vitro using pieces of pancreas removed from the golden hamster (11) and in vivo in rats (13) and men (12) infused with NH4+. A role for NH4+ in the abnormality of islet function seen in cirrhotic patients (12,31) was also documented.…”
Section: Methodsmentioning
confidence: 90%
“…Cirrhosis is characterized by a number of abnormalities in circulating substrate and hormone concentrations including FFA (13)(14)(15), glucagon (54), growth hormone (55), norepinephrine (56), and insulin itself(l-8). Moreover, an increase in each of these substrates has been shown to be associated with the development of insulin resistance.…”
Section: Discussionmentioning
confidence: 99%